Showing results (391-400 of 457) with videos related to

Sort By:
Pageof 46
The EMBO Journal|February 24, 2007
AP endonuclease paralogues with distinct activities in DNA repair and bacterial pathogenesisElisabeth P Carpenter, Anne Corbett, Hellen Thomson, et al.
International Journal of Geriatric Psychiatry|September 28, 2022
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analysesRamakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.
Trials|May 29, 2013
Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT)Linda Clare, Antony Bayer, Alistair Burns, et al.
Lancet (London, England)|September 25, 2025
Treatment for Alzheimer's diseaseNick C Fox, Christopher Belder, Clive Ballard, et al.
BMJ Open|March 1, 2022
PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trialJane L Cross, Simon P Hammond, Lee Shepstone, et al.
The Lancet Regional Health. Europe|April 24, 2023
Autism in England: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care dataElizabeth O'Nions, Irene Petersen, Joshua E J Buckman, et al.
Brain Pathology (Zurich, Switzerland)|July 30, 2019
Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunctionYoshiki Hase, Tuomo M Polvikoski, Michael J Firbank, et al.
Nature Reviews. Neurology|April 24, 2020
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disordersNicholas J Ashton, Abdul Hye, Anto P Rajkumar, et al.
Geroscience|May 2, 2025
Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effectsMiguel German Borda, Robinson Ramírez-Vélez, Felipe Botero-Rodriguez, et al.
JAMA Neurology|November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical TrialRobert Howard, Olga Zubko, Rosie Bradley, et al.
Pageof 46